FindTrial
Sign In

Molecular analysis of cancers in the large intestine in patients that use statins.

Molecular analysis of colorectal cancers in patients receiving statin therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25857
Enrollment
Unknown
Registered
2008-08-20
Start date
2008-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal carcinoma, Statins/statines, BMP, SMAD4, chemoprevention

Interventions

None
molecular analysis

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Primary diagnosis of colorectal carcinoma between 1st of January 2000 and 31st of December 2007 in the Netherlands and registered in the PHARMO RLS.

Exclusion criteria

Exclusion criteria: - Medical history of colorectal cancer, chemotherapy and/or radiotherapy

Design outcomes

Primary

MeasureTime frame
- Less SMAD4 positive colorectal cancers in Statin users—

Secondary

MeasureTime frame
- Survival—

Contacts

Public ContactR.J. Jacobs

LUMC Department of Gastroenterology and Hepatology

R.J.Jacobs@lumc.nl+31 (0)71 5262915

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)